Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) agreed to acquire Certain Epidemiological Data Infrastructure Assets from Baktus, Inc. on August 19, 2022. Under the terms of the deal, Ginkgo will assume ownership of proprietary datasets, modeling and analytic tools, and a software platform with the capabilities to track, model, and forecast epidemics and associated risks and impacts. Ginkgo also expects to integrate several ongoing epidemiological analysis projects and a team of epidemiological data experts into its biosecurity and public health initiative, Concentric by Ginkgo.

Baktus and Metabiota are expected to continue their independent operations after transferring the assets and epidemiological data personnel included in this transaction. Nita Madhav, outgoing Chief Executive Officer of Metabiota, who will be joining Ginkgo as part of the transaction.